ARID1A suppresses R-loop mediated STING-Type I Interferon pathway activation of anti-tumor immunity
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 62 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 62 samples: 56 distinct titles, 6 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunityCell · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE217807_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA900585 and SRA study SRP407497. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 4 samples read as cases, 12 as controls.
How we read this: Read from 62 sample titles: 56 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6726996 sgScr_ATAC_rep1
- GSM6726997 sgScr_ATAC_rep2
- GSM6726998 sgArid1a_ATAC_rep1
- GSM6726999 sgArid1a_ATAC_rep2
- GSM6727000 WT_MEFs_STAT1_ChIP_Seq
- GSM6727001 WT_MEFs_STAT2_ChIP_Seq
- GSM6727002 WT_MEFs_IRF9_ChIP_Seq
- GSM6727003 Arid1a_KO_MEFs_STAT1_ChIP_Seq
- GSM6727004 Arid1a_KO_MEFs_STAT2_ChIP_Seq
- GSM6727005 Arid1a_KO_MEFs_IRF9_ChIP_Seq
- GSM6727006 WT_input_ChIP_Seq
- GSM6727007 sgScr_CD8_T_cell_scRNA_rep1
- GSM6727008 sgScr_CD8_T_cell_scRNA_rep2
- GSM6727009 sgArid1a_CD8_T_cell_scRNA_rep1
- GSM6727010 sgArid1a_CD8_T_cell_scRNA_rep2
- GSM7981832 sgScr_B16F10_tumor_rep1_RNAseq
- GSM7981833 sgScr_B16F10_tumor_rep2_RNAseq
- GSM7981834 sgArid1a_B16F10_tumor_rep1_RNAseq
- GSM7981835 sgArid1a_B16F10_tumor_rep2_RNAseq
- GSM7981836 sgScr_PBS_B16F10_rep1_RNAseq
- GSM7981837 sgScr_PBS_B16F10_rep2_RNAseq
- GSM7981838 sgArid1a_PBS_B16F10_rep1_RNAseq
- GSM7981839 sgArid1a_PBS_B16F10_rep2_RNAseq
- GSM7981840 sgScr_IFNg_B16F10_rep1_RNAseq
- GSM7981841 sgScr_IFNg_B16F10_rep2_RNAseq
- GSM7981842 sgArid1a_IFNg_B16F10_rep1_RNAseq
- GSM7981843 sgArid1a_IFNg_B16F10_rep2_RNAseq
- GSM7981844 sgScr_B16F10_rep1_RNAseq
- GSM7981845 sgScr_B16F10_rep2_RNAseq
- GSM7981846 sgArid1a_B16F10_rep1_RNAseq
- GSM7981847 sgArid1a_B16F10_rep2_RNAseq
- GSM7981848 Cgas_dKO_B16F10_rep1_RNAseq
- GSM7981849 Cgas_dKO_B16F10_rep2_RNAseq
- GSM7981850 Sting_dKO_B16F10_rep1_RNAseq
- GSM7981851 Sting_dKO_B16F10_rep2_RNAseq
- GSM7981852 sgArid1a_anti_IFNAR_B16F10_rep1_RNAseq
- GSM7981853 sgArid1a_anti_IFNAR_B16F10_rep2_RNA_seq
- GSM7981854 sgScr_DMSO_JAKi_exp_B16F10_rep1_RNAseq
- GSM7981855 sgScr_DMSO_JAKi_exp_B16F10_rep2_RNAseq
- GSM7981856 sgArid1a_DMSO_B16F10_rep1_RNAseq
+ 22 more — browse all 62 samples with per-sample file links →
- GSE217803 ARID1A suppresses R-loop mediated STING-Type I Interferon pathway activation of anti-tumor immunity (RNA-Seq) 46 samples shares arid1a, suppresses, sting-type, interferon, activation, anti-tumor, mediated, immunity
- GSE295483 Type-I interferon priming signal balances anti-bacterial and anti-tumor trained immunity in alveolar macrophages [RNA-seq] 19 samples shares interferon, anti-tumor, immunity
- GSE297709 STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity 18 samples shares interferon, anti-tumor, immunity
- GSE332761 Baseline interferon signaling in monocytes and antibody-mediated innate activation at injection site shape mRNA vaccine reactogenicity 16 samples shares interferon, activation, mediated
- GSE236247 The Interferon γ Pathway Enhances Pluripotency and X-Chromosome Reactivation in iPSC Reprogramming 68 samples shares interferon, activation
- GSE313654 Activated Interferon Signaling Suppresses Age-Dependent Liver Cancer [RNAseq_MycRux] 58 samples shares suppresses, interferon
- GSE289723 Interleukin-4 modulates type I interferon to augment anti-tumour immunity [scRNA-Seq] 36 samples shares interferon, immunity
- GSE289722 Interleukin-4 modulates type I interferon to augment anti-tumour immunity 30 samples shares interferon, immunity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.